Topics
May/June 2026 | Letter to the Editors - Online Exclusive
Beyond One-Size-Fits-All: The Move Toward Personalized Vitreoretinal Therapy
By calculating the vitreous volume exact, clinicians can treat eyes with greater precision.
Andreas F. Borkenstein, MD
June 9, 2026
Optos Appoints Alexandre Montague as Chief Executive Officer
Heidelberg Engineering Receives FDA Clearance for Enhanced Imaging Software on Spectralis
June 8, 2026
Alkeus Doses First Patient in Global Phase 3 NORTHSTAR Trial of Gildeuretinol for Stargardt Disease
FDA Issues Draft Guidance to Accelerate Development of Gene Therapies Using Existing Scientific Knowledge
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
